SCHEMBL7029643

SCHEMBL7029643

COc1cccc(C(N)c2ccccc2)c1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.51
TDO2 P48775 1/20 0.51
NFE2L2 Q16236 1/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
MAPT P10636 3/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
TDP2 O95551 1/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
MAPK1 P28482 1/20 0.41
CYP19A1 P11511 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9680973 0.87 IDO1 (0.59) IDO1TDO2MEN1KMT2AALDH1A1
SCHEMBL20241687 0.87 IDO1 (0.59) IDO1TDO2MEN1KMT2AALDH1A1
SCHEMBL31145921 0.82 MEN1 (0.50) IDO1TDO2NFE2L2MEN1KMT2A
SCHEMBL29105289 0.79 MAPT (0.51) IDO1TDO2NFE2L2MEN1KMT2A
SCHEMBL28318660 0.79 IDO1 (0.56) IDO1TDO2NFE2L2MEN1KMT2A
SCHEMBL4100987 0.78 SMN1; SMN2 (0.44) NFE2L2MEN1KMT2AMAPTALDH1A1
SCHEMBL3979394 0.78 SMN1; SMN2 (0.44) NFE2L2MEN1KMT2AMAPTALDH1A1
SCHEMBL2252742 0.78 SMN1; SMN2 (0.44) NFE2L2MEN1KMT2AMAPTALDH1A1
Hydrochloric Acid SCHEMBL3700107 0.77 ALDH1A1 (0.44) IDO1TDO2MEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL3660925 0.77 ALDH1A1 (0.44) IDO1TDO2MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0804231-B1 SYNTHETIC MULTIPLE TANDEM REPEAT MUCIN AND MUCIN-LIKE PEPTIDES, AND USES THEREOF FINN OLIVERA J (US) 2003-02-05 EP disclosed
EP-0804231-A4 SYNTHETIC MULTIPLE TANDEM REPEAT MUCIN AND MUCIN-LIKE PEPTIDES, AND USES THEREOF FINN OLIVERA J (US) 1999-08-18 EP disclosed
US-5827666-A FOR DETECTING ANTIBODIES TO PANCREATIC, BREAST, COLON CANCER UNIVERSITY OF PITTSBURGH (US) 1998-10-27 US disclosed
US-5744144-A CANCER VACCINE UNIVERSITY OF PITTSBURGH UNIVERSITY PATENT COMMITTEE POLICY AND PROCEDURES (US) 1998-04-28 US disclosed
EP-0804231-A1 SYNTHETIC MULTIPLE TANDEM REPEAT MUCIN AND MUCIN-LIKE PEPTIDES, AND USES THEREOF Finn, Olivera J. (US) 1997-11-05 EP disclosed
WO-1997028187-A2 MULTIVALENT CHIMERIC PEPTIDES AS MICROBICIDES THE POPULATION COUNCIL (US) 1997-08-07 WO disclosed
US-5609876-A Peptide vaccines and associated methods for protection against feline leukemia virus UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 1997-03-11 US disclosed
WO-1995003825-A1 SYNTHETIC MULTIPLE TANDEM REPEAT MUCIN AND MUCIN-LIKE PEPTIDES, AND USES THEREOF FINN OLIVERA J (US) 1995-02-09 WO disclosed
US-4257947-A INTERMEDIATES FOR ANTIBACTERIAL CEPHALOSPORINS SMITHKLINE CORPORATION (US) 1981-03-24 US disclosed
US-4166816-A CYCLIZATION SMITHKLINE CORPORATION (US) 1979-09-04 US disclosed
US-4085100-A Intermediate for dephthaloylation of azetidinone compounds SMITHKLINE CORPORATION (US) 1978-04-18 US disclosed
US-4072674-A FOR CEPHALOSPORIN CONGENERS SMITHKLINE CORPORATION (US) 1978-02-07 US disclosed